Pharming (PHAR) Return on Assets [ROA] (2021 - 2026)
Pharming (PHAR) reported Return on Assets [ROA] of -1.82% for Q3 2026, up 3.66 percentage points from -5.48% a year earlier and up 0.01 percentage points from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Pharming posted Return on Assets [ROA] of 0.56%, up 3.97 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of -10.63 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -3.41% in FY2024 (-1.03 pp), -2.37% in FY2023 (-9.25 pp), 6.88% in FY2022 (+2.95 pp) and 3.92% in FY2021 (-7.27 pp).
- The Q3 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q1 2023.
- Year over year, Return on Assets [ROA] has now increased in each of the last five quarters, with an average year-over-year change of +0.74 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q3 2022 (a gain of 10.84 percentage points); the low point was Q3 2023 (a drop of 26.50 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -1.83% (Q2 2026), -3.14% (Q1 2026) and -5.18% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Pharming | 927.62 Mn | 229.29 Mn | 102.20 | -1.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1.82% |
| Jun 30, 2026 | -1.84% |
| Mar 31, 2026 | -3.14% |
| Dec 31, 2025 | -5.18% |
| Sep 30, 2025 | -5.48% |
| Jun 30, 2025 | -6.20% |
| Mar 31, 2025 | -7.38% |
| Dec 31, 2024 | -6.59% |
| Sep 30, 2024 | -7.21% |
| Jun 30, 2024 | -6.01% |
| Mar 31, 2024 | -2.38% |
| Dec 31, 2023 | -2.34% |
| Sep 30, 2023 | -5.09% |
| Jun 30, 2023 | -3.85% |
| Mar 31, 2023 | -0.47% |
| Dec 31, 2022 | 6.43% |
| Sep 30, 2022 | 21.41% |
| Jun 30, 2022 | 8.33% |
| Mar 31, 2022 | 5.80% |
| Dec 31, 2021 | 7.00% |
API Access
Pharming Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();